Author:
Meruva Saikishore,Thool Prajwal,Gong Yuchuan,Agrawal Anjali,Karki Shyam,Bowen William,Mitra Biplob,Kumar Sumit
Funder
Bristol-Myers Squibb Co Summit
Reference39 articles.
1. Trends in CMO market of high potency drugs;Vatsa;Am Pharm Rev,2019
2. Tiene G. Targeted, highly potent therapies: big growth driver for the CDMO market is here., ed. 2016. Available at: https://www.pharmasalmanac.com/articles/targeted-highly-potent-therapies-big-growth-driver-for-the-cdmo-market-le-here. Accessed June 25, 2021.
3. Formulation and Analytical Development for Low-Dose Oral Drug Products;Zheng,2009
4. Performance-based exposure control limits for pharmaceutical active ingredients;Naumann;Am Ind Hyg Assoc,1996
5. Prediction of drug particle size and content uniformity in low-dose solid dosage forms;Huang;Int J Pharm,2010
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献